Lion Point Capital, LP Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001643354
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2023 · 29 positions · Total reported value $159.36M · Top-10 concentration 92.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 2.9% · 0 new · 1 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +28.8% · vs SPY +14.0% · Prev Value $16.73M — last quarter positions weighted by this quarter price moves · ranking
In its Q3 2023 13F filing, Lion Point Capital, LP disclosed 29 equity positions with a combined reported value of $159.36M. The filing implies a focused portfolio: its ten largest positions account for 92.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / Buy & Hold.
The largest disclosed positions as of Q3 2023 were SMTC ($63.16M), IWM ($29.16M), SPY ($21.37M). By sector, the heaviest allocations are Technology 39.7%, Health Care 10.8%.
Versus the prior quarter, Lion Point Capital, LP opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 2.9% of positions.
The largest new positions opened in Q3 2023 were SMTC ($63.16M), IWM ($29.16M), SPY ($21.37M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2023)
- SMTC SEMTECH CORP · $63.16M
- IWM ISHARES TR · $29.16M
- SPY STATE STR SPDR S&P 500 ETF T · $21.37M
- MRNS MARINUS PHARMACEUTICALS INC · $17.27M
- ARDX ARDELYX INC · $4.80M
- BFICQ BURGERFI INTERNATIONAL INC · $3.19M
- BATL BATTALION OIL CORP · $2.35M
- KNSA KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · $2.27M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Lion Point Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Lion Point Capital, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 35 US equity positions with a combined value of $20.91M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-81004 (status: Approved), registered 2015-02-25
- Regulatory AUM (Form ADV): $480.60M as of 2026-04-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 5 private funds, of which 2 hedge funds
- Website: lionpoint.com
Portfolio Structure
- 35 positions · $20.91M reported value (Q2 2026)
- Top 10 holdings = 55.0% of reported value
- Largest position: CUE (Cue Biopharma Inc) at 8.0%
- Average position size: $597.29K
Sector Tilt
- Health Care 98.8%
- Information Technology 1.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 reduced
- 34 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.45M | $63.16M | 39.63% | New | |
| 2 |
|
165.00K | $29.16M | 18.30% | New | |
| 3 |
|
50.00K | $21.37M | 13.41% | New | |
| 4 |
|
2.15M | $17.27M | 10.84% | New | |
| 5 |
|
1.18M | $4.80M | 3.01% | New | |
| 6 |
|
2.75M | $3.19M | 2.00% | New | |
| 7 |
|
380.89K | $2.35M | 1.48% | New | |
| 8 |
|
130.69K | $2.27M | 1.43% | New | |
| 9 |
|
70.33K | $1.78M | 1.11% | New | |
| 10 |
|
691.80K | $1.65M | 1.03% | New | |
| 11 |
|
531.26K | $1.62M | 1.01% | New | |
| 12 |
|
450.21K | $1.40M | 0.88% | New | |
| 13 |
|
82.42K | $1.23M | 0.77% | New | |
| 14 |
|
427.45K | $1.06M | 0.67% | New | |
| 15 |
|
27.00K | $853.20K | 0.54% | New | |
| 16 |
|
110.00K | $826.10K | 0.52% | New | |
| 17 |
|
80.00K | $824.00K | 0.52% | New | |
| 18 |
|
115.90K | $793.90K | 0.50% | New | |
| 19 |
|
235.00K | $688.55K | 0.43% | New | |
| 20 |
|
1.00M | $647.93K | 0.41% | New | |
| 21 |
|
35.00K | $598.85K | 0.38% | New | |
| 22 |
|
34.50K | $500.94K | 0.31% | New | |
| 23 |
|
82.42K | $398.93K | 0.25% | New | |
| 24 |
|
82.46K | $332.31K | 0.21% | New | |
| 25 |
|
90.79K | $299.62K | 0.19% | New | |
| 26 |
|
2.08M | $235.43K | 0.15% | New | |
| 27 |
|
100 | $31.57K | 0.02% | New | |
| 28 |
|
100 | $13.19K | 0.01% | New | |
| 29 |
|
46 | $7.76K | 0.01% | New | |
FAQ
What did Lion Point Capital, LP buy in 2023-Q3?
In its 2023-Q3 13F filing, Lion Point Capital, LP reported 29 equity positions worth $159.36M in aggregate; its largest disclosed positions were SMTC ($63.16M), IWM ($29.16M), SPY ($21.37M).
How large is Lion Point Capital, LP's portfolio?
Lion Point Capital, LP reported $159.36M of long equity holdings across 29 positions as of 2023-Q3. Top-10 holdings account for 92.2% of reported value.
What is Lion Point Capital, LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.